Abstract
Sarcopenic dysphagia is the term for swallowing difficulty associated with loss of mass, strength, and physical performance, which leads to increased pharyngeal residues. Unlike sarcopenia, presarcopenia is characterized by low muscle mass without decreased muscle strength or physical performance and can develop into dysphagia due to low skeletal muscle mass. This retrospective study investigated the impact of presarcopenic dysphagia (PSD) on 1-year mortality in patients with cancer and dysphagia who underwent a videofluoroscopic swallowing study (VFSS). An operational definition of PSD based on presarcopenia and pharyngeal residues was adopted. The psoas muscle mass index (cm2/height [m2]), calculated by the psoas muscle area at the third lumber vertebra via abdominal computed tomography (CT) and related to height, was used to assess presarcopenia with cutoff values of 4.62 for men and 2.66 for women. Pharyngeal residues were assessed using a VFSS to evaluate dysphagia. Patients’ medical charts were analyzed to investigate 1-year mortality after a VFSS. Out of 111 consecutive patients with cancer, 53 (47.7%) were defined as having PSD. In a forward-stepwise Cox proportional regression analysis, PSD (HR 2.599; 95% CI 1.158–5.834; p = 0.021) was significantly associated with 1-year mortality after a VFSS, even after adjusting for the factors of operation, Functional Oral Intake Scale (FOIS) scores at discharge, and modified Barthel Index (BI) scores at discharge. PSD, defined as CT-based presarcopenia and pharyngeal residues observed during a VFSS, is associated with increased 1-year mortality in patients with cancer and dysphagia.
Similar content being viewed by others
Data Availability
All data are not publically available owing to opt-out restrictions. Data sharing is not applicable.
References
Fujisihima I, Fujiu-Kurachi M, Arai H, et al. Sarcopenia and dysphagia: position paper by four professional organizations. Geriatr Gerontol Int. 2019;19:91–7. https://doi.org/10.1111/ggi.13591.
Pamoukdjian F, Bouillet T, Lévy V, et al. Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: a systematic review. Clin Nutr. 2018;37:1101–13. https://doi.org/10.1016/j.clnu.2017.07.010.
Otten L, Stobäus N, Franz K, et al. Impact of sarcopenia on 1-year mortality in older patients with cancer. Age Ageing. 2019;48:413–8. https://doi.org/10.1093/ageing/afy212.
Frowen J, Hughes R, Skeat J. The prevalence of patient-reported dysphagia and oral complications in cancer patients. Support Care Cancer. 2020;28:1141–50. https://doi.org/10.1007/s00520-019-04921-y.
Molfenter SM, Amin MR, Branski RC, et al. Age-related changes in pharyngeal lumen size: a retrospective MRI analysis. Dysphagia. 2015;30:321–7. https://doi.org/10.1007/s00455-015-9602-9.
Miyashita T, Kikutani T, Nagashima K, et al. The effects of sarcopenic dysphagia on the dynamics of swallowing organs observed on videofluoroscopic swallowing studies. J Oral Rehabil. 2020;47:584–90. https://doi.org/10.1111/joor.12936.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–23. https://doi.org/10.1093/ageing/afq034.
Hanna L, Nguo K, Furness K, et al. Association between skeletal muscle mass and quality of life in adults with cancer: a systematic review and meta-analysis. J Cahexia Sarcopenia Muscle. 2022;13:839–57. https://doi.org/10.1002/jcsm.12928.
Sakai M, Sohda M, Saito H, et al. Impact of combined assessment of systemic inflammation and presarcopenia on survival for surgically resected esophageal cancer. Am J Surg. 2021;221:149–54. https://doi.org/10.1016/j.amjsurg.2020.05.029.
Takada H, Kurosaki M, Nakanishi H, et al. Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma. PLoS ONE. 2018;13:e0198812. https://doi.org/10.1371/journal.pone.0198812.
Takada H, Amemiya F, Yasumura T, et al. Relationship between presarcopenia and event occurrence in patients with primary hepatocellular carcinoma. Sci Rep. 2020;10:10186. https://doi.org/10.1038/s41598-020-67147-7.
Bahat G, Turkmen BO, Aliyev S, et al. Cut-off values of skeletal muscle index and psoas muscle index at L3 vertebra level by computerized tomography to assess low muscle mass. Clin Nutr. 2021;40:4360–5. https://doi.org/10.1016/j.clnu.2021.01.010.
Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. A simple index of independence useful in scoring improvement in the rehabilitation of the chronically ill. Md State Med J. 1965;14:61–5.
Crary MA, Mann GDC, Groher ME. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil. 2005;86:1516–20. https://doi.org/10.1016/j.apmr.2004.11.049.
Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83. https://doi.org/10.1016/0021-9681(87)90171-8.
Campo-Rivera N, Ocampo-Chaparro JM, Carvajal-Ortiz R, et al. Sarcopenic dysphagia is associated with mortality in institutionalized older adults. J Am Med Dir Assoc. 2022;23:1720.e11-1720.e17. https://doi.org/10.1016/j.jamda.2022.06.016.
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8. https://doi.org/10.1038/bmt.2012.244.
Wakabayashi H. Presbyphagia and sarcopenic dysphagia: association between aging, sarcopenia, and deglutition disorders. J Frailty Aging. 2014;3:97–103. https://doi.org/10.14283/jfa.2014.8.
Hamaguchi Y, Kaido T, Okumura S, et al. Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults. Nutrition. 2016;32:1200–5. https://doi.org/10.1016/j.nut.2016.04.003.
Wakabayashi H, Takahashi R, Watanabe N, et al. Prevalence of sarcopenia and its association with dysphagia in cancer patients who require rehabilitation. J Rehabil Med. 2017;49:682–5. https://doi.org/10.2340/16501977-2253.
Mayanagi S, Ishikawa A, Matsui K, et al. Association of preoperative sarcopenia with postoperative dysphagia in patients with thoracic esophageal cancer. Dis Esophagus. 2021;34:doaa121. https://doi.org/10.1093/dote/doaa121.
Clavé P, Arreola V, Romea M, et al. Accuracy of the volume-viscosity swallow test for clinical screening of oropharyngeal dysphagia and aspiration. Clin Nutr. 2008;27:806–15. https://doi.org/10.1016/j.clnu.2008.06.011.
Mizuno S, Wakabayashi H, Fujishima I, et al. Construction and quality evaluation of the Japanese Sarcopenic Dysphagia Database. J Nutr Health Aging. 2021;25(7):926–32. https://doi.org/10.1007/s12603-021-1646-y.
Wu BW, Yin T, Cao WX, et al. Clinical application of subjective global assessment in Chinese patients with gastrointestinal cancer. World J Gasteroenterol. 2009;15:3542–9. https://doi.org/10.3748/wjg.15.3542.
Pressoir M, Desné S, Berchery D, et al. Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. Br J Cancer. 2010;102:966–71. https://doi.org/10.1038/sj.bjc.6605578.
Braun DP, Gupta D, Staren ED. Quality of life assessment as a predictor of survival in non-small cell lung cancer. BMC Cancer. 2011;11:353. https://doi.org/10.1186/1471-2407-11-353.
Kenis C, Decoster L, Bastin J, et al. Functional decline in older patients with cancer receiving chemotherapy: a multicenter prospective study. J Geriatr Oncol. 2017;8:196–205. https://doi.org/10.1016/j.jgo.2017.02.010.
Morishma T, Sato A, Nakata K, et al. Geriatric assessment domains to predict overall survival in older cancer patients: an analysis of functional status, comorbidities, and nutritional status as prognostic factors. Cancer Med. 2020;16:5839–50. https://doi.org/10.1002/cam4.3205.
Funding
This study was not financially supported.
Author information
Authors and Affiliations
Contributions
TM conceived the idea of the study, developed the statistical analyses, and drafted the original manuscript on intellectual content. AH and YM contributed to interpreting the results and revised the original manuscript. MT, RH, HT, HI, and MO contributed to collecting the data for the study. SS supervised the conduct of the study. All Authors reviewed the manuscript draft and approved publishing the final version.
Corresponding author
Ethics declarations
Conflict of Interests
The authors declare no conflict of interest.
Ethical Approval
This study was conducted under the Declaration of Helsinki and with the approval of the Ethics Committee of the University Hospital of Occupational and Environmental Health, Japan [UOEHCRB22-144]. Written informed consent was not obtained because of the retrospective observational nature of the study. Nevertheless, all patients were allowed to provide an opt-out option to withdraw from the study at any time.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Moriyama, T., Hachisuka, A., Matsusihima, Y. et al. Impact of Presarcopenic Dysphagia on 1-Year Mortality After Videofluoroscopic Swallowing Study in Patients with Cancer. Dysphagia (2024). https://doi.org/10.1007/s00455-023-10652-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00455-023-10652-4